Literature DB >> 21826708

Ailanthoidol suppresses lipopolysaccharide-stimulated inflammatory reactions in RAW264.7 cells and endotoxin shock in mice.

Jin-Kyung Kim1, Jong-Gab Jun.   

Abstract

The biological properties of ailanthoidol, a neolignan from Zanthoxylum ailanthoides or Salvia miltiorrhiza Bunge, which is used in Chinese traditional herbal medicine, have not been evaluated. Here, we report that ailanthoidol inhibits inflammatory reactions in macrophages and protects mice from endotoxin shock. Our in vitro experiments showed that ailanthoidol suppressed the generation of nitric oxide (NO) and prostaglandin E(2) , as well as the expression of inducible NO synthase (iNOS) and cyclooxygenase (COX)-2 induced by lipopolysaccharide (LPS) in RAW264.7 cells. Similarly, ailanthoidol inhibited the production of inflammatory cytokines induced by LPS in RAW264.7 cells, including interleukin (IL)-1β and IL-6. In an animal model, ailanthoidol protected BALB/c mice from LPS-induced endotoxin shock, possibly through inhibition of the production of inflammatory cytokines and NO. Collectively, ailanthoidol inhibited the production of inflammatory mediators and may be a potential target for treatment of various inflammatory diseases.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21826708     DOI: 10.1002/jcb.23312

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  Suppression of the Proliferation of Huh7 Hepatoma Cells Involving the Downregulation of Mutant p53 Protein and Inactivation of the STAT 3 Pathway with Ailanthoidol.

Authors:  Tsui-Hwa Tseng; Chau-Jong Wang; Yean-Jang Lee; Yi-Chia Shao; Chien-Heng Shen; Ko-Chao Lee; Shui-Yi Tung; Hsing-Chun Kuo
Journal:  Int J Mol Sci       Date:  2022-05-04       Impact factor: 6.208

2.  Adenosine 5'-monophosphate ameliorates D-galactosamine/lipopolysaccharide-induced liver injury through an adenosine receptor-independent mechanism in mice.

Authors:  Y Zhan; Z Wang; P Yang; T Wang; L Xia; M Zhou; Y Wang; S Wang; Z Hua; J Zhang
Journal:  Cell Death Dis       Date:  2014-01-09       Impact factor: 8.469

3.  Semi-synthesis, structural modification and biological evaluation of 5-arylbenzofuran neolignans.

Authors:  Ding Lin; Long Wang; Zhongzhong Yan; Jiao Ye; Aixi Hu; Hongdong Liao; Juan Liu; Junmei Peng
Journal:  RSC Adv       Date:  2018-10-05       Impact factor: 3.361

4.  2-(4-Hydroxyphenyl)-5-(3-Hydroxypropenyl)-7-Methoxybenzofuran, a Novel Ailanthoidol Derivative, Exerts Anti-Inflammatory Effect through Downregulation of Mitogen-Activated Protein Kinase in Lipopolysaccharide-Treated RAW 264.7 Cells.

Authors:  Hyeon Jin Kim; Jong-Gab Jun; Jin-Kyung Kim
Journal:  Korean J Physiol Pharmacol       Date:  2013-06-11       Impact factor: 2.016

5.  XH-14, a novel danshen methoxybenzo[b]furan derivative, exhibits anti-inflammatory properties in lipopolysaccharide-treated RAW 264.7 cells.

Authors:  Geun-Mook Park; Jong-Gab Jun; Jin-Kyung Kim
Journal:  J Inflamm (Lond)       Date:  2013-01-10       Impact factor: 4.981

6.  Toxoplasma ROP16I/III ameliorated inflammatory bowel diseases via inducing M2 phenotype of macrophages.

Authors:  Yong-Wei Xu; Rui-Xin Xing; Wen-Hui Zhang; Lu Li; Yi Wu; Jing Hu; Cong Wang; Qing-Li Luo; Ji-Long Shen; Xi Chen
Journal:  World J Gastroenterol       Date:  2019-12-07       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.